Elevated Blood Sugar Tied to Higher Death Risk in Peritoneal Dialysis Patients: Study
South Korea: A new study published in the Journal of Diabetes has highlighted the significant impact of fasting blood glucose (FBG) levels on mortality risk among patients undergoing peritoneal dialysis (PD).
The study found that the risk of all-cause mortality increased when fasting blood glucose levels surpassed 125 mg/dL in peritoneal dialysis patients with diabetes. Additionally, there was a strong correlation between elevated FBG levels and cardiovascular death compared to other causes of death.
Peritoneal dialysis (PD) is a common treatment for patients with end-stage renal disease, but managing complications and improving survival rates remain key challenges. This study specifically focused on the role of fasting blood glucose, a marker commonly associated with diabetes, in predicting mortality risks for PD patients.
Glycemic control is essential for PD patients with diabetes. While FBG is widely used to monitor blood glucose levels, there is currently no established evidence linking FBG levels to mortality risk in this patient population. Therefore, Hyeon Seok Hwang, Kyung Hee University, College of Medicine, Seoul, Republic of Korea, and colleagues examined the connection between fasting blood glucose levels and the risk of all-cause mortality in diabetic peritoneal dialysis patients. Additionally, the study aimed to assess how FBG levels are associated with the risk of specific causes of death to determine which mortality causes are most influenced by glucose levels.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.